Top Stock Research Reports for Roche, Royal Dutch Shell & CitigroupZacks Investment Research • 01/21/20
Roche Finishes Year With Big Deals, Gene Therapy In Focus As Competition Heats UpSeeking Alpha • 12/30/19
How Does Johnson & Johnson’s Revenue And Other Key Metrics Compare With That of Roche?Forbes • 12/26/19
How Much Revenue Does Roche’s Pharmaceutical Business Generate From The United States?Forbes • 12/26/19
Sarepta: Roche Partnership After The FDA's Turnaround Forms The Basis For A $158.59 Near-Term Price TargetSeeking Alpha • 12/26/19
Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001GlobeNewsWire • 12/23/19
Approval Of The Spark Deal Only Part Of An Expanding R&D-Driven Opportunity At RocheSeeking Alpha • 12/17/19